Kymera Therapeutics (KYMR) Times Interest Earned (2019 - 2026)
Kymera Therapeutics' (KYMR) quarterly Times Interest Earned came in at -$0.2 in Q1 2026, up 66.41% year-on-year from -$0.12 in Q1 2025, and up 44.61% on a QoQ basis from -$0.37 in Q3 2025.
Kymera Therapeutics (KYMR) Times Interest Earned (2019 - 2026) Analysis & Trends
Kymera Therapeutics (KYMR) has 8 years of Times Interest Earned data on file, last reported at -$0.2 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 66.41% year-over-year to -$0.2 in Q1 2026; TTM through Mar 2026 was -$0.87, a 61.65% increase from a year earlier, with the FY2025 full-year figure at -$0.87, up 21.24% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.2, up from -$0.37 in the prior quarter.
- Over the last five years, Times Interest Earned for KYMR reached as high as -$0.12 in Q4 2023 and fell as low as -$5047.2 in Q4 2024.
- Historically, Times Interest Earned has averaged -$359.81 across 5 years, with a median of -$0.55 in 2025.
- Across the five-year window, Times Interest Earned soared 99.98% in 2023 and plunged 4243567.51% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$702.36 in 2022, then surged by 99.98% to -$0.12 in 2023, then plunged by 4243567.51% to -$5047.2 in 2024, then jumped by 99.99% to -$0.37 in 2025, then jumped by 44.61% to -$0.2 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.2 in Q1 2026, -$0.37 in Q3 2025, and -$0.63 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Kymera Therapeutics | 10.77 Bn | 10.11 Bn | - | -0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.20 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -0.63 |
| Mar 31, 2025 | -0.61 |
| Dec 31, 2024 | -5,047.19 |
| Sep 30, 2024 | -0.48 |
| Jun 30, 2024 | -0.89 |
| Mar 31, 2024 | -0.44 |
| Dec 31, 2023 | -0.12 |
| Sep 30, 2023 | -0.45 |
| Jun 30, 2023 | -0.35 |
| Mar 31, 2023 | -0.68 |
| Dec 31, 2022 | -702.36 |
| Sep 30, 2022 | -0.91 |
| Jun 30, 2022 | -0.92 |
| Mar 31, 2022 | -0.28 |
| Dec 31, 2021 | -492.67 |
| Sep 30, 2021 | -0.12 |
| Jun 30, 2021 | -0.13 |
| Mar 31, 2021 | -0.08 |